Open original FDA record ↗Recall record
- FDA identifier
- Z-0068-2010
- Company in FDA record
- Boston Scientific Corporation
- FDA classification date
- Oct 21, 2009
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Boston Scientific initiated a field correction for the Liberte Bare-Metal coronary stent products. They have received reports from cardiac cath labs that TAXUS Liberte Paclitaxel-Eluting (TAXUS Libert Drug-Eluting) coronary stents have been inadvertently selected when the interventional cardiologist intended to implant a Liberte Bare-Metal stent, and Libert Bare-Metal stents have been ina
Source facts
- Action
- Boston Scientific issued an "Urgent Medical Device Field Correction" letter dated September 18, 2009. The letter was addressed to Risk Manger/Field Action Contact. The letter described the product, problem and actions which included renaming the Liberte Bare-Metal stent as VeriFlex" Bare-Metal stent. Enclosed with the letter included the Direction for Field Correction and a Reply Verification Tracking Form. For further information, contact you local Boston Scientific Sales Representative or call 1-800-811-3211.
- Initiated
- 2009-09-11
- Root cause
- Labeling design
- Terminated
- 2012-06-28
- Distribution
- Nationwide Distribution -- United States including Puerto Rico.
- Recall number
- Z-0068-2010
- Recall status
- Terminated
- CDRH record ID
- 85496
- FDA classified
- 2009-10-21
- Recall event number
- 53435